| 1 |
16284058 | Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study. | 2006 Feb |
1 |
| 2 |
15169628 | Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells. | 2004 Jun |
1 |
| 3 |
12181445 | Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine. | 2002 Sep |
1 |
| 4 |
12191604 | Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2. | 2002 Feb-Mar |
3 |
| 5 |
10665655 | G1-checkpoint function including a cyclin-dependent kinase 2 regulatory pathway as potential determinant of 7-hydroxystaurosporine (UCN-01)-induced apoptosis and G1-phase accumulation. | 1999 Dec |
1 |
| 6 |
8645257 | UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. | 1996 Feb 27 |
2 |
| 7 |
7574801 | [Cell cycle regulation by anticancer agent]. | 1995 Oct |
1 |